Search

Your search keyword '"Schedl, Timothy"' showing total 70 results

Search Constraints

Start Over You searched for: Author "Schedl, Timothy" Remove constraint Author: "Schedl, Timothy"
70 results on '"Schedl, Timothy"'

Search Results

1. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

2. Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalities

3. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

4. Cohort Expansion and Genotype-Phenotype Analysis of RAB11A-Associated Neurodevelopmental Disorder

5. Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly

6. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

7. De novo variants in DENND5B cause a neurodevelopmental disorder

8. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

9. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

10. Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care

11. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

12. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

13. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

14. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

15. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

16. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

17. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

18. De novo variants in DENND5B cause a neurodevelopmental disorder

19. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

20. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

21. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

22. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

23. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

24. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

25. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

26. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

27. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

28. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

29. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

30. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

31. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

32. One is the loneliest number: genotypic matchmaking using the electronic health record

33. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

34. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

35. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

36. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

37. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

38. Dominant missense variants in SREBF2are associated with complex dermatological, neurological, and skeletal abnormalities

39. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

40. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

41. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

42. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

43. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

44. Loss-of-function in RBBP5results in a syndromic neurodevelopmental disorder associated with microcephaly

45. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

46. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

47. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

48. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

49. Variants in PRKAR1Bcause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

50. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

Catalog

Books, media, physical & digital resources